Do you offer PARP inhibitor maintenance retreatment of platinum-sensitive, relapsed, high grade serous ovarian cancer in patients who had a complete response to their most recent platinum-based chemo?  

Front-line PARP inhibitor maintenance therapy discontinued without progression.



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Sweetwater Regional Medical Center
So, Niraparib is for all ovarian cancer patients a...
Medical Oncologist at University of Utah School of Medicine
In the NOVA trial, patients in the niraparib group...
Medical Oncologist
Does the OReO/ENGOT Ov-38 study discussed at ESMO ...
Sign in or Register to read more

Answer from: at Academic Institution